牛牛AI助理已提取核心訊息
Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Virpax Pharmicals, Inc. [VRPX] 的舉報人芭芭拉·拉斯金於2024年1月29日參與了該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。建議投資者尋求更多信息，以充分了解這一事件對其投資決策的影響。
Virpax Pharmicals, Inc. [VRPX] 的舉報人芭芭拉·拉斯金於2024年1月29日參與了該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。建議投資者尋求更多信息，以充分了解這一事件對其投資決策的影響。
有用
沒用
